Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey Cover

.blurhash-client-img { display: none !important; }

Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey

Radiology and Oncology

Volume 48 (2014): Issue 1 (March 2014)

By: Marina Hodolic, Laure Michaud, Virginie Huchet, Sona Balogova, Valérie Nataf, Khaldoun Kerrou, Marika Vereb, Jure Fettich and Jean-Noël Talbot

Open Access

|Jan 2014

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2013-0049 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 20 - 28

Published on: Jan 22, 2014

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

prostate cancer,

fluorocholine (FCH),

bone scintigraphy,

indication of imaging

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2014 Marina Hodolic, Laure Michaud, Virginie Huchet, Sona Balogova, Valérie Nataf, Khaldoun Kerrou, Marika Vereb, Jure Fettich, Jean-Noël Talbot, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Previous article Volume 48 (2014): Issue 1 (March 2014)Next article